<DOC>
	<DOCNO>NCT01709461</DOCNO>
	<brief_summary>purpose study extend use Rasagelin Mesylate 1mg per day subject participate Adagio TVP 1012/501 accord form 4a additional three year .</brief_summary>
	<brief_title>Continuation Treatment Protocol Patients Who Participated Adagio TVP 1012/501 Clinical Trial</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>subject willing contiue treatment . subject take part TVP 1012/501 clinical trail . subject n't take part TVP 1012/501 clinical trail .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2012</verification_date>
</DOC>